Board Advisory & Strategic Consulting

I work with boards, VCs, and C-suites in clinical research, biotech, and pharma on:

• Strategic advisory (M&A, post-merger integration, geographic expansion)
• Board governance (performance optimization, crisis leadership)
• Executive performance (discipline, resilience, data-driven decision-making)

What sets me apart

I’m not just advising on performance—I’m demonstrating it in real-time. Olympic-level discipline. Measurable progress.

Boards don’t need another consultant with theories. They need someone who proves impossible goals are possible—and shows them how.

Keynote Speaking

I speak to C-suite executives, boards, VCs, and leaders navigating high-stakes decisions — on impossible goals, identity under pressure, and the discipline behind elite performance.

Signature Topics

Impossible Goals Are Just Well-Executed Plans The framework behind 20 years of Fortune 500 execution — and what happens when you apply it to a goal everyone else thinks is unrealistic. A practical, evidence-based approach to audacious achievement.
First, Only, Different What it actually costs to be the first woman, the only outsider, the different one in the room — and what comes after you decide to leave. For leaders carrying the weight of representation.
The Courage to Start Over Leaving at the peak, not the bottom. The psychology of deliberate reinvention, the golden handcuffs problem, and why the most dangerous career trap has nothing to do with failure.
Discipline, Agency, Impact The three pillars of high performance — in boardrooms and arenas. How the same operating system drives excellence across domains.

Also Available On

Health equity and access in clinical research
Women in leadership — advancing beyond the glass ceiling
Leadership resilience under sustained pressure
Bioethics and the future of drug development

Past Stages

United Nations General Assembly (UNGA79) · UNESCO · TEDx · London School of Economics · Open Eyes Economy Summit · Healthcare Businesswomen’s Association

Featured In

Forbes · Newsweek · Al Jazeera · 50+ outlets across Europe and internationally